Rutin’s cardioprotective promise: a systematic review of mechanisms and efficacy in non-clinical chemotoxicity models

Chemotherapy remains a crucial part of cancer treatment, markedly alleviating the societal burden of the disease. Nonetheless, the advantageous therapeutic effects of these drugs are generally accompanied by significant unfavorable consequences, including damage to healthy tissues, with heart toxicity being a primary concern. Rutin, a phyto-antioxidant, has considerable potential to regulate disorders associated with oxidative stress, inflammation, and apoptosis. This review systematically evaluates the efficacy of rutin in protecting the heart against injury induced by chemotherapeutic agents. In this study, the search terms were selected based on the research purpose and used to examine the titles and abstracts of papers. After a comprehensive examination of the literature in databases (PubMed, ISI, and Scopus) up to December 2025, adhering to PRISMA guidelines, 193 papers were evaluated, and 14 studies were chosen based on established inclusion and exclusion criteria. Data analysis revealed that many categories of chemotherapeutic drugs induce detrimental cardiac side effects in both in vitro and in vivo models. Co-treatment with rutin significantly reversed detrimental changes and maintained heart function and physiological parameters. The preventive properties of rutin primarily stem from its ability to reduce oxidative stress, downregulate inflammatory pathways, and prevent cell death. Although preliminary findings from animal studies suggest potential benefits of co-administering rutin with chemotherapy, additional clinical trials are necessary to determine whether rutin may compromise the efficacy of chemotherapeutic agents and to evaluate its safety and effectiveness as a cardioprotective supplement for cancer patients.

Authors

Institutions

Publication Details

Journal
BMC Cancer
Published
2026-11-18
DOI
https://doi.org/10.1186/s12885-026-17359-3
Primary Topic
Chemotherapy-induced cardiotoxicity and mitigation
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Rutin’s cardioprotective promise: a systematic review of mechanisms and efficacy in non-clinical chemotoxicity models

Hamed Haghi‐Aminjan, Mohammad Reza Abdollahi, Mahban Rahimifard, Niyousha Heidary
3 links
BMC Cancer
Chemotherapy-induced cardiotoxicity and mitigation
article

Rutin’s cardioprotective promise: a systematic review of mechanisms and efficacy in non-clinical chemotoxicity models

Hamed Haghi‐Aminjan, Mohammad Reza Abdollahi, Mahban Rahimifard, Niyousha Heidary
article en

Abstract

Chemotherapy remains a crucial part of cancer treatment, markedly alleviating the societal burden of the disease. Nonetheless, the advantageous therapeutic effects of these drugs are generally accompanied by significant unfavorable consequences, including damage to healthy tissues, with heart toxicity being a primary concern. Rutin, a phyto-antioxidant, has considerable potential to regulate disorders associated with oxidative stress, inflammation, and apoptosis. This review systematically evaluates the efficacy of rutin in protecting the heart against injury induced by chemotherapeutic agents. In this study, the search terms were selected based on the research purpose and used to examine the titles and abstracts of papers. After a comprehensive examination of the literature in databases (PubMed, ISI, and Scopus) up to December 2025, adhering to PRISMA guidelines, 193 papers were evaluated, and 14 studies were chosen based on established inclusion and exclusion criteria. Data analysis revealed that many categories of chemotherapeutic drugs induce detrimental cardiac side effects in both in vitro and in vivo models. Co-treatment with rutin significantly reversed detrimental changes and maintained heart function and physiological parameters. The preventive properties of rutin primarily stem from its ability to reduce oxidative stress, downregulate inflammatory pathways, and prevent cell death. Although preliminary findings from animal studies suggest potential benefits of co-administering rutin with chemotherapy, additional clinical trials are necessary to determine whether rutin may compromise the efficacy of chemotherapeutic agents and to evaluate its safety and effectiveness as a cardioprotective supplement for cancer patients.

BMC Cancer
Pharmaceutical Sciences Research Center (IR), Tehran University of Medical Sciences (IR)
Tehran University of Medical Sciences and Health Services
Good health and well-being
Chemotherapy-induced cardiotoxicity and mitigation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon